Roles of erythroid differentiation regulator 1 (Erdr1) on inflammatory skin diseases

Youn Kyung Houh, Kyung Eun Kim, Hyun Jeong Park, Dae Ho Cho

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Erythroid Differentiation Regulator 1 (Erdr1) is known as a hemoglobin synthesis factor which also regulates cell survival under conditions of stress. In addition, previous studies have revealed the effects of Erdr1 on cancer progression and its negative correlation with interleukin (IL)-18, a pro-inflammatory cytokine. Based on this evidence, the therapeutic effects of Erdr1 have been demonstrated in several inflammatory skin diseases such as malignant skin cancer, psoriasis, and rosacea. This article reviews the roles of Erdr1 in skin inflammation, suggesting that Erdr1 is a potential therapeutic molecule on inflammatory disorders.

Original languageEnglish
Article number2059
JournalInternational journal of molecular sciences
Volume17
Issue number12
DOIs
Publication statusPublished - 2016 Dec 8
Externally publishedYes

Fingerprint

Rosacea
Interleukin-18
regulators
Skin Neoplasms
Therapeutic Uses
Psoriasis
Skin Diseases
Cell Survival
Skin
Hemoglobins
Cytokines
Inflammation
Neoplasms
Hemoglobin
cancer
interleukins
Therapeutics
Cells
hemoglobin
Molecules

Keywords

  • Cutaneous inflammation
  • Erdr1
  • IL-18
  • Melanoma
  • Psoriasis
  • Rosacea

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Roles of erythroid differentiation regulator 1 (Erdr1) on inflammatory skin diseases. / Houh, Youn Kyung; Kim, Kyung Eun; Park, Hyun Jeong; Cho, Dae Ho.

In: International journal of molecular sciences, Vol. 17, No. 12, 2059, 08.12.2016.

Research output: Contribution to journalReview article

@article{e5c5d89d75704b628266381d06449585,
title = "Roles of erythroid differentiation regulator 1 (Erdr1) on inflammatory skin diseases",
abstract = "Erythroid Differentiation Regulator 1 (Erdr1) is known as a hemoglobin synthesis factor which also regulates cell survival under conditions of stress. In addition, previous studies have revealed the effects of Erdr1 on cancer progression and its negative correlation with interleukin (IL)-18, a pro-inflammatory cytokine. Based on this evidence, the therapeutic effects of Erdr1 have been demonstrated in several inflammatory skin diseases such as malignant skin cancer, psoriasis, and rosacea. This article reviews the roles of Erdr1 in skin inflammation, suggesting that Erdr1 is a potential therapeutic molecule on inflammatory disorders.",
keywords = "Cutaneous inflammation, Erdr1, IL-18, Melanoma, Psoriasis, Rosacea",
author = "Houh, {Youn Kyung} and Kim, {Kyung Eun} and Park, {Hyun Jeong} and Cho, {Dae Ho}",
year = "2016",
month = "12",
day = "8",
doi = "10.3390/ijms17122059",
language = "English",
volume = "17",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "12",

}

TY - JOUR

T1 - Roles of erythroid differentiation regulator 1 (Erdr1) on inflammatory skin diseases

AU - Houh, Youn Kyung

AU - Kim, Kyung Eun

AU - Park, Hyun Jeong

AU - Cho, Dae Ho

PY - 2016/12/8

Y1 - 2016/12/8

N2 - Erythroid Differentiation Regulator 1 (Erdr1) is known as a hemoglobin synthesis factor which also regulates cell survival under conditions of stress. In addition, previous studies have revealed the effects of Erdr1 on cancer progression and its negative correlation with interleukin (IL)-18, a pro-inflammatory cytokine. Based on this evidence, the therapeutic effects of Erdr1 have been demonstrated in several inflammatory skin diseases such as malignant skin cancer, psoriasis, and rosacea. This article reviews the roles of Erdr1 in skin inflammation, suggesting that Erdr1 is a potential therapeutic molecule on inflammatory disorders.

AB - Erythroid Differentiation Regulator 1 (Erdr1) is known as a hemoglobin synthesis factor which also regulates cell survival under conditions of stress. In addition, previous studies have revealed the effects of Erdr1 on cancer progression and its negative correlation with interleukin (IL)-18, a pro-inflammatory cytokine. Based on this evidence, the therapeutic effects of Erdr1 have been demonstrated in several inflammatory skin diseases such as malignant skin cancer, psoriasis, and rosacea. This article reviews the roles of Erdr1 in skin inflammation, suggesting that Erdr1 is a potential therapeutic molecule on inflammatory disorders.

KW - Cutaneous inflammation

KW - Erdr1

KW - IL-18

KW - Melanoma

KW - Psoriasis

KW - Rosacea

UR - http://www.scopus.com/inward/record.url?scp=85006132388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006132388&partnerID=8YFLogxK

U2 - 10.3390/ijms17122059

DO - 10.3390/ijms17122059

M3 - Review article

C2 - 27941650

AN - SCOPUS:85006132388

VL - 17

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 12

M1 - 2059

ER -